United Kingdom · Series C startup
9 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 7 months ago
Follow STORM Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$317Mraised across 9 rounds since 2016, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Fast Track Initiative and 1 other
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by FinSMEs
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
IP Group
Pfizer
Cambridge Innovation Capital
Taiho Ventures
Innovate UK
M Ventures
UTokyo Innovation Platform
Seroba Life Sciences
Fast Track InitiativeImperial InnovationsMissing a round, or an investor who was in one? Tell us.
These 2 firms list STORM Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
STORM Therapeutics's investors include IP Group, Pfizer, Cambridge Innovation Capital, Taiho Ventures and Innovate UK, and 5 more on record.
STORM Therapeutics has raised $317M across 9 rounds since 2016.
STORM Therapeutics's most recent round was a Series C of $56M in Apr 2026.
STORM Therapeutics's largest round on record is $73M, in Jan 2025.
STORM Therapeutics's first round on record, in Jun 2016, was backed by Cambridge Innovation Capital and Imperial Innovations.
STORM Therapeutics's latest named round is a Series C, in Apr 2026.
STORM Therapeutics is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
